Virtu Financial’s Virtus Biotech ETF BBP Stock Holding History

Virtu Financial’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-29,795	Closed	-$1.23M	–	1979
2018 Q1	$1.23M	Buy	29,795 +10,387	+54%	+$437K	0.07%	293
2017 Q4	$787K	Buy	19,408 +4,822	+33%	+$192K	0.04%	556
2017 Q3	$606K	Buy	+14,586	New	+$583K	0.03%	773

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Virtu Financial's BBP Position: Q2 2018 in Review

Virtu Financial sold out of Virtus Biotech ETF (BBP) in Q2 2018, closing a stake of 29,795 shares — an estimated $1.23M sold.

Virtu Financial first reported a position in BBP in Q3 2017 and held it in 3 quarters. The position peaked at $1.23M in Q1 2018. 17 funds tracked by Wall St. Rank hold BBP as of Q2 2018.

Virtu Financial reported no remaining Virtus Biotech ETF position as of Q2 2018 after selling out during the quarter.
Virtu Financial sold 29,795 Virtus Biotech ETF shares in Q2 2018, an estimated $1.23M.
Virtu Financial first reported a position in Virtus Biotech ETF in Q3 2017 and held it in 3 quarters.
Virtu Financial's Virtus Biotech ETF position peaked at $1.23M in Q1 2018.
17 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.